This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Aegerion Pharmaceuticals Inc
AEGR : NASDAQ : Health Care

$45.23 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 1,046,100
04/22/14 - 4:00 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
AEGR AEGERION PHARMACEUTICALS INC 42.04 1211.21 n/m 1.23 n/a
ALNY ALNYLAM PHARMACEUTICALS INC 23.95 1481.71 n/m 66.73 -19.38
GEVA SYNAGEVA BIOPHARMA CORP 51.69 1409.28 n/m 14.95 826.51
IMGN IMMUNOGEN INC 16.02 1349.24 n/m 34.66 74.06
IRWD IRONWOOD PHARMACEUTICALS INC 15.21 1251.59 n/m 141.25 108.08
NPSP NPS PHARMACEUTICALS INC 13.43 1250.55 n/m 130.64 28.52
MNKD MANNKIND CORP 3.95 1142.98 n/m 0.04 -30.00
PDLI PDL BIOPHARMA INC 7.74 1083.47 5.27 374.53 6.38
CLDX CELLDEX THERAPEUTICS INC 13.05 1055.35 n/m 11.20 20.90
ACAD ACADIA PHARMACEUTICALS INC 12.89 1016.81 n/m 4.91 137.39
LXRX LEXICON PHARMACEUTICALS INC 1.98 1015.75 n/m 1.09 -41.11
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

AEGR Ind Avg S&P 500
n/m 32.35 18.47

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs